4D Molecular Therapeutics (FDMT) Amortizatization of Intangibles (2021 - 2025)

4D Molecular Therapeutics (FDMT) has disclosed Amortizatization of Intangibles for 5 consecutive years, with -$656000.0 as the latest value for Q4 2025.

  • Quarterly Amortizatization of Intangibles fell 111.28% to -$656000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.9 million through Dec 2025, down 59.19% year-over-year, with the annual reading at $2.9 million for FY2025, 59.19% down from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was -$656000.0 at 4D Molecular Therapeutics, down from $1.2 million in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $5.8 million in Q4 2024, with the low at -$2.2 million in Q4 2022.
  • Average Amortizatization of Intangibles over 5 years is $478950.0, with a median of $376000.0 recorded in 2021.
  • Peak annual rise in Amortizatization of Intangibles hit 5189.09% in 2024, while the deepest fall reached 432.95% in 2024.
  • Over 5 years, Amortizatization of Intangibles stood at -$1.8 million in 2021, then decreased by 17.76% to -$2.2 million in 2022, then surged by 105.09% to $110000.0 in 2023, then surged by 5189.09% to $5.8 million in 2024, then plummeted by 111.28% to -$656000.0 in 2025.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods came in at -$656000.0, $1.2 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.